First Horizon Corporation’s Akebia Therapeutics AKBA Stock Holding History

First Horizon Corporation’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$0	Hold	63	–	–	﹤0.01%	1058
2021 Q1	$0	Hold	63	–	–	﹤0.01%	1040
2020 Q4	$0	Buy	+63	New	+$184	﹤0.01%	1034

Other funds holding AKBA

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Horizon Corporation's AKBA Position: Q2 2021 in Review

First Horizon Corporation held its Akebia Therapeutics (AKBA) position steady in Q2 2021 at 63 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

First Horizon Corporation first reported a position in AKBA in Q4 2020 and has held it in 3 quarters since. 139 funds tracked by Wall St. Rank hold AKBA as of Q2 2021.

First Horizon Corporation held 63 shares of Akebia Therapeutics worth $0 as of Q2 2021.
First Horizon Corporation left its Akebia Therapeutics share count unchanged in Q2 2021.
Akebia Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #1058 holding.
First Horizon Corporation first reported a position in Akebia Therapeutics in Q4 2020 and has held it in 3 quarters since.
139 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.